PETACC-8 miR-31-3p and miR-31-5p Ancillary Study

计划入组 1,808 人 · 首次发布于 2017 年 12 月 5 日

miR-342-5p/AnkG Pathway in Early AD Synaptic Dysfunction

计划入组 40 人 · 首次发布于 2026 年 1 月 20 日

The Relation Between MiR-125b-5p and Staging of Endometriosis

计划入组 89 人 · 首次发布于 2022 年 9 月 27 日

miR-221-5p

EBV-miR-BART1-5p-antagomiRs

miR-31-5p inhibitor (bone disorders)

MIR SCIENTIFIC LLC

United States

Regulus Therapeutics

United States

MIE UNIVERSITY

Japan

Exosomes Emerge as Dual-Purpose Tools in Cancer: From Drug Resistance Mechanisms to Therapeutic Delivery Systems

HDAC Inhibition in Muscle Cells Enhances Bone Regeneration via Extracellular Vesicles

cGAS-STING Pathway Shows Dual Role in Breast Cancer Immunotherapy Response